AAC just published a review from the WHO advisory panel on the antibacterial pipeline analyzing ‘traditional’ and ‘non-traditional’ antibacterial agents and modulators in clinical development current on 30 June 2021 with activity against the WHO priority pathogens, mycobacteria and Clostridioides difficile. Today, we will dissect this important publication
Topics Discussed:
- The role of the WHO in antimicrobial resistance.
- The analysis of the antibacterial pipeline.
- Important highlights from the review and the future of antibacterial research.
Guests:
- Dr. Peter Beyer, Senior Advisor for the Antimicrobial Resistance Division at the World Health Organization.
- Dr. Mark Butler, MSBChem Consulting, Brisbane, Queensland, Australia.
- Dr. Prabhavathi Fernandes. Member, Scientific Advisory Committee, GARDP, Geneva, Switzerlandand The National Biodefense Science 17Board, Health and Human Services, Washington, D.C.
Visit to browse issues and/or submit a manuscript.
Subscribe to Editors in Conversation (free) on , , , or by .